Daily Price Movement / General Discussion, page-32649

First 32649 Last

Share
Profile

Follow
Goodfella58

4,257 Posts.

1869

12/10/21

00:57

Post #: 56724350
Share

Originally posted by Goodfella58: ↑

STAGFLATION'S GRIM TRACK RECORD (1155 GMT)

As stagflation worries take centre stage, Goldman Sachs strategists have reviewed equity performance in environments of high inflation and slowing growth for the past 60 years.

"U.S. equity investors have had little experience with stagflation in recent decades," the team led by David Kostin wrote in the investment bank's U.S. Weekly Kickstart note.

Since 1960, 41 quarters have been characterized by weak GDP growth and high inflation, mostly between the late 1960s and early 1980s, the strategists found.

The S&P 500 quarterly return fell 2.1% in those periods versus median real total return of 2.5% per quarter in the last 6 decades.

The equity performance in stagflationary environments was worse than the median returns in environments characterized solely by either weak economic growth or high inflation, the Goldman Sachs team also said.

Consumer services industries like restaurants and entertainment have outperformed goods industries including apparel and retail by over 100 bps per quarter during stagflationary periods compared with roughly equivalent performance in all periods.

Stagflation also weighed on the growth of household wealth, with these period being associated with declining household allocations to equities, helping explain the weakness in equity valuation multiples.

At the sector level, energy and health care have typically generated the strongest returns during periods of stagflation, while industrials and tech have generally lagged most, according to the GS strategists.

Expand

Z1P Price at posting: $6.87 Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

There are more pages in this discussion • 13,909 more messages in this thread...

First 32649 Last

Add ZIP (ASX) to my watchlist

(20min delay)
Last $1.72		Change -0.045(2.56%)		Mkt cap ! $1.915B

Open	High	Low	Value	Volume
$1.80	$1.83	$1.70	$25.11M	14.37M

Buyers (Bids)

No.	Vol.	Price($)
8	19331	$1.80

Sellers (Offers)

Price($)	Vol.	No.
$1.63	3344	2

View Market Depth

No.	Vol.	Price($)
1	59071	1.840
5	16430	1.805
8	19331	1.800
4	55121	1.790
3	44145	1.770

Price($)	Vol.	No.
1.545	2528	3
1.600	25000	1
1.625	63241	4
1.630	5844	3
1.660	2488	5

Last trade - 15.59pm 11/07/2024 (20 minute delay)

ZIP (ASX) Chart

Daily Price Movement / General Discussion, page-32649

Canadian fieldwork yields multiple pegmatites for Trinex

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Daily Price Movement / General Discussion, page-32649

Top Stories

Canadian fieldwork yields multiple pegmatites for Trinex

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News